In March 2025, the company declared new designs for any direct-to-client featuring of its Wegovy weight loss drug. The company established a fresh pharmacy, known as NovoCare, which might demand prospects $499 a month for access to the drug, fewer than half the expense of the drug by means of other pharmaceutical distribution networks.[fifty three]